Stay updated on Durva + Domva After ChemoRad in Stage III NSCLC Clinical Trial
Sign up to get notified when there's something new on the Durva + Domva After ChemoRad in Stage III NSCLC Clinical Trial page.

Latest updates to the Durva + Domva After ChemoRad in Stage III NSCLC Clinical Trial page
- CheckyesterdayChange DetectedA new research site was added in Columbus, Ohio (United States, 43214). The total number of locations increased from 263 to 264.SummaryDifference0.1%

- Check8 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2; no changes to core study content or user-facing information were observed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check15 days agoChange DetectedAdded a site revision label v3.4.1; removed the funding-status notice and the earlier revision label v3.4.0.SummaryDifference0.1%

- Check22 days agoChange DetectedLocation entry for India (122001) changed from Gurgaon to Gūrgaon, adding a macron to the city name. This aligns the listing with localized spelling and ensures consistent site identification for recruitment and mapping.SummaryDifference0.0%

- Check30 days agoChange DetectedThe study's location count updated to 263 locations (from 264), affecting the recruitment site list and related location details; the page now includes a 'Show glossary' option.SummaryDifference0.2%

- Check37 days agoChange DetectedThe page version label was updated from v3.3.3 to v3.3.4, a minor metadata change. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Durva + Domva After ChemoRad in Stage III NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durva + Domva After ChemoRad in Stage III NSCLC Clinical Trial page.